Global Neurodegenerative Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026

  • ID:PD016122
  • April 2020
  • Value Market Research
                          

The report on the Global Neurodegenerative Drugs Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
 
Drivers

  • Advancement in medical technology
  • New drug launches
 
Restraints
  • Disease Complexity
 
Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Till: 2026
 
The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
 
The report classifies the market into different segments based on indication type and drug type. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
 
The report also covers the complete competitive landscape of the global Neurodegenerative Drugs market with company profiles of key players such as:
  • Novartis
  • Pfizer
  • Merck Serono
  • Biogen Idec
  • TEVA Pharmaceuticals Industries
  • UCB
  • Bayer Schering
  • Boehringer Ingelheim
  • Sanofi S.A.
  • GlaxoSmithKline

A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.
 
SEGMENTATIONS IN THE REPORT:
By Indication Type:
  • Parkinson’s Disease
  • Amyotrophic Lateral Sclerosis
  • Alzheimer’s Disease
  • Huntington Disease
  • Others

By Drug Type:
  • NMDA
  • SSRI
  • Dopamine Inhibitors
  • Others
 
By Geography:
  • North America (NA)
  • Europe (EU)
  • Asia Pacific (APAC)
  • Latin America (LA)
  • Middle East & Africa (MEA)

The Global Neurodegenerative Drugs Market has been exhibited in detail in the following chapters -
Chapter 1 Neurodegenerative Drugs Market Preface 
Chapter 2 Executive Summary
Chapter 3 Neurodegenerative Drugs Industry Analysis
Chapter 4 Neurodegenerative Drugs Market Value Chain Analysis
Chapter 5 Neurodegenerative Drugs Market Analysis By Indication Type
Chapter 6 Neurodegenerative Drugs Market Analysis By Drug Type
Chapter 7 Neurodegenerative Drugs Market Analysis By Geography
Chapter 8 Competitive Landscape Of Neurodegenerative Drugs Companies
Chapter 9 Company Profiles Of Neurodegenerative Drugs Industry
 
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

  • DecisionDatabases.com also provides specific research reports as per Client requirement.
  • Based on the feasibility, data can be provided for custom segmentation
 
DELIVERABLE OPTIONS:
 
DecisionDatabases.com also provides Mini Report and Sections of Reports, in case Client does not want to buy the full report: 
  • Market Data Sheet with all Tables and Graphs
  • Mini Report
  • Analysis
    • Drivers
    • Restraints
    • SWOT Analysis
    • Patent Analysis
  • Application Analysis
  • Product Analysis
  • Geography Analysis
  • Company Analysis
  • Competitive Landscape
  • Location of Plants
  • Company Profiles

TABLE OF CONTENTS
 
1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Neurodegenerative Drugs Market
       2.2. Global Neurodegenerative Drugs Market Snapshot
 
3 . NEURODEGENERATIVE DRUGS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Neurodegenerative Drugs Market
       3.3. Market Restraints of Neurodegenerative Drugs Market
       3.4. Opportunities of Neurodegenerative Drugs Market
       3.5. Trends of Neurodegenerative Drugs Market
       3.6. Porter’s Five Force Analysis of Neurodegenerative Drugs Market
       3.7. Neurodegenerative Drugs Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Indication Type
           3.7.2 Market Attractive Analysis by Drug Type
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Neurodegenerative Drugs Value Chain Analysis
       4.2. Neurodegenerative Drugs Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Neurodegenerative Drugs Raw Material Manufactures List
           4.2.3. Price Trend of Neurodegenerative Drugs Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL NEURODEGENERATIVE DRUGS MARKET ANALYSIS BY INDICATION TYPE
       5.1 Overview by Indication Type
       5.2 Global Neurodegenerative Drugs Market Analysis by Indication Type
       5.3 Market Analysis of Parkinson’s Disease by Regions
       5.4 Market Analysis of Amyotrophic Lateral Sclerosis by Regions
       5.5 Market Analysis of Alzheimer’s Disease by Regions
       5.6 Market Analysis of Huntington Disease by Regions
       5.7 Market Analysis of Others by Regions
 
6 . GLOBAL NEURODEGENERATIVE DRUGS MARKET ANALYSIS BY DRUG TYPE
       6.1 Overview by Drug Type
       6.2 Global Neurodegenerative Drugs Market Analysis by Drug Type
       6.3 Market Analysis of NMDA by Regions
       6.4 Market Analysis of SSRI by Regions
       6.5 Market Analysis of Dopamine Inhibitors by Regions
       6.6 Market Analysis of Others by Regions
 
7 . GLOBAL NEURODEGENERATIVE DRUGS MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Neurodegenerative Drugs Market Estimate by Market Segment
           7.3.3. North America Neurodegenerative Drugs Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Neurodegenerative Drugs Market Estimate by Market Segment
           7.4.3. Europe Neurodegenerative Drugs Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Neurodegenerative Drugs Market Estimate by Market Segment
           7.5.3. Asia Pacific Neurodegenerative Drugs Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Neurodegenerative Drugs Market Estimate by Market Segment
           7.6.3. Latin America Neurodegenerative Drugs Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Neurodegenerative Drugs Market Estimate by Market Segment
           7.7.3. Middle East & Africa Neurodegenerative Drugs Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE NEURODEGENERATIVE DRUGS COMPANIES
       8.1. Neurodegenerative Drugs Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF NEURODEGENERATIVE DRUGS INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Novartis
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Pfizer
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Merck Serono
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Biogen Idec
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. TEVA Pharmaceuticals Industries
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. UCB
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Bayer Schering
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Boehringer Ingelheim
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Sanofi S.A.
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
       9.12. GlaxoSmithKline
           9.12.1. Company Overview
           9.12.2. Financials
           9.12.3. Products
           9.12.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Neurodegenerative Drugs Market Snapshot
  • Drivers of The Global Neurodegenerative Drugs Market Impact Analysis
  • Restraints of The Global Neurodegenerative Drugs Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Parkinson’s Disease by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Amyotrophic Lateral Sclerosis by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Alzheimer’s Disease by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Huntington Disease by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Others by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis by Drug Type (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in NMDA by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in SSRI by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Dopamine Inhibitors by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Others by Geography (USD MN)
  • Global Neurodegenerative Drugs Market by Geography (USD MN)
  • North America Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • North America Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • North America Neurodegenerative Drugs Market Estimate by Country (USD MN)
  • United State Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • United State Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Rest of North America Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Rest of North America Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Europe Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Europe Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • United Kingdom Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • United Kingdom Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • France Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • France Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Germany Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Germany Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Rest of Europe Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Rest of Europe Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Asia Pacific Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Asia Pacific Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Asia Pacific Neurodegenerative Drugs Market Estimate by Country (USD MN)
  • China Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • China Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Japan Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Japan Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • India Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • India Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Rest of Asia Pacific Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Rest of Asia Pacific Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Latin America Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Latin America Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Latin America Neurodegenerative Drugs Market Estimate by Country (USD MN)
  • Brazil Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Brazil Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Rest of Latin America Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Rest of Latin America Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Middle East & Africa Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Middle East & Africa Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Middle East & Africa Neurodegenerative Drugs Market Estimate by Country (USD MN)
  • Middle East Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Middle East Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Africa Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Africa Neurodegenerative Drugs Market Estimate by Drug Type (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Neurodegenerative Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Neurodegenerative Drugs Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Indication Type
  • Market Attractiveness Analysis by Drug Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Neurodegenerative Drugs Market Analysis by Indication Type (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Parkinson’s Disease by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Amyotrophic Lateral Sclerosis by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Alzheimer’s Disease by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Huntington Disease by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Others by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis by Drug Type (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in NMDA by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in SSRI by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Dopamine Inhibitors by Geography (USD MN)
  • Global Neurodegenerative Drugs Market Analysis in Others by Geography (USD MN)
  • Latin America Neurodegenerative Drugs Market by Revenue
  • Middle East & Africa Neurodegenerative Drugs Market by Revenue
  • Recent Development in Neurodegenerative Drugs Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks  read more..


Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on  read more..


Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..